UroGen Pharma director awarded RSUs and options
UroGen Pharma Ltd. director Leana Wen reported receiving new equity awards as part of her compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
UroGen Pharma Ltd. director Leana Wen reported receiving new equity awards as part of her compensation. She was granted 8,000 restricted stock units, each representing a right to receive one ordinary share, and 10,000 stock options to purchase ordinary shares at an exercise price of $34.99 per share.
The RSUs and the shares underlying the options will vest in equal quarterly installments over one year, contingent on her continued service under the company’s 2017 Equity Incentive Plan. These are grants and do not involve any open-market buying or selling of shares.
Insider Trade Summary
Grant/Award: 18,000 shares
Grant/Award
2 txns
Insider
WEN LEANA
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right ot buy) | 10,000 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit | 8,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right ot buy) — 10,000 contracts (Direct);
Restricted Stock Unit — 8,000 contracts (Direct)
Footnotes (3)
- F1. The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.
- F2. Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- F3. The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.
Key Figures
Restricted stock units granted: 8,000 units
Stock options granted: 10,000 options
Option exercise price: $34.99 per share
+3 more
6 metrics
Restricted stock units granted
8,000 units
RSU grant to director on June 22, 2026
Stock options granted
10,000 options
Option grant to director on June 22, 2026
Option exercise price
$34.99 per share
Stock option strike price for ordinary shares
Option expiration date
June 22, 2036
Expiration of director stock options
Underlying shares for RSUs
8,000 shares
Each RSU represents one ordinary share
Underlying shares for options
10,000 shares
Ordinary shares subject to stock options
Key Terms
Restricted Stock Unit, Continuous Service, 2017 Equity Incentive Plan, stock option
4 terms
Restricted Stock Unit financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Continuous Service financial
"subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan)"
2017 Equity Incentive Plan financial
"as defined in the 2017 Equity Incentive Plan through such vesting dates"
stock option financial
"The shares underlying the stock option will vest in equal quarterly installments"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did UroGen Pharma (URGN) director Leana Wen report in this Form 4?
Leana Wen reported receiving equity compensation awards from UroGen Pharma. She was granted 8,000 restricted stock units and 10,000 stock options, both tied to the company’s ordinary shares and subject to a one-year quarterly vesting schedule based on continued service.
How many restricted stock units did Leana Wen receive from UroGen Pharma (URGN)?
Leana Wen received 8,000 restricted stock units from UroGen Pharma. Each RSU represents a contingent right to receive one ordinary share, vesting in equal quarterly installments over one year, provided she maintains Continuous Service under the 2017 Equity Incentive Plan.
What are the terms of the UroGen Pharma (URGN) stock options granted to Leana Wen?
Leana Wen was granted 10,000 stock options to buy UroGen Pharma ordinary shares at $34.99 per share. These options vest in equal quarterly installments over one year and expire on June 22, 2036, assuming she continues to meet the plan’s service requirements.
Does this UroGen Pharma (URGN) Form 4 show any open-market stock purchases or sales?
The Form 4 reports only grant or award acquisitions of RSUs and stock options, not open-market trades. It shows no purchases or sales of shares in the market, only compensation-related equity awards that vest over time based on continued service.
How do the RSUs granted to Leana Wen at UroGen Pharma (URGN) vest?
The RSUs vest in equal quarterly installments over one year. Each installment is contingent on Leana Wen’s Continuous Service, as defined in UroGen Pharma’s 2017 Equity Incentive Plan, through each applicable vesting date before shares are delivered.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates